← Back to Screener
GLOBUS MEDICAL INC (GMED)
Price$96.82
Favorite Metrics
Price vs S&P 500 (26W)61.52%
Price vs S&P 500 (4W)2.88%
Market Capitalization$12.85B
P/E Ratio (Annual)23.90x
All Metrics
P/CF (Annual)17.06x
Book Value / Share (Quarterly)$33.86
P/TBV (Annual)3.07x
Revenue Growth (3Y)42.17%
Cash Flow / Share (Quarterly)$4.29
Price vs S&P 500 (YTD)6.96%
Gross Margin (TTM)67.41%
Net Profit Margin (TTM)18.30%
EPS (TTM)$3.93
10-Day Avg Trading Volume1.10M
EPS Excl Extra (TTM)$3.93
Revenue Growth (5Y)30.08%
EPS (Annual)$3.92
ROI (Annual)11.76%
Gross Margin (Annual)67.41%
Net Profit Margin (5Y Avg)12.88%
Cash / Share (Quarterly)$4.13
P/E Basic Excl Extra (TTM)23.90x
Revenue Growth QoQ (YoY)25.73%
EPS Growth (5Y)31.11%
P/E Normalized (Annual)23.90x
ROA (Last FY)10.14%
Revenue Growth TTM (YoY)16.65%
EBITD / Share (TTM)$5.25
ROE (5Y Avg)7.23%
Operating Margin (TTM)20.33%
Cash Flow / Share (Annual)$4.29
P/B Ratio2.81x
P/B Ratio (Quarterly)2.57x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)4.20x
Net Interest Coverage (TTM)3.54x
ROA (TTM)10.72%
EPS Growth QoQ (YoY)442.70%
EV / EBITDA (TTM)17.14x
EPS Incl Extra (Annual)$3.92
Current Ratio (Annual)4.26x
Quick Ratio (Quarterly)2.61x
3-Month Avg Trading Volume1.25M
52-Week Price Return36.35%
EV / Free Cash Flow (Annual)21.29x
P/E Incl Extra (TTM)23.90x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$28.35
P/S Ratio (Annual)4.37x
Asset Turnover (Annual)0.55x
52-Week High$101.40
Operating Margin (5Y Avg)15.13%
EPS Excl Extra (Annual)$3.92
CapEx CAGR (5Y)22.32%
Tangible BV CAGR (5Y)21.95%
26-Week Price Return68.41%
Quick Ratio (Annual)2.61x
13-Week Price Return3.12%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.26x
Enterprise Value$12,329.184
Revenue / Share Growth (5Y)22.38%
Asset Turnover (TTM)0.59x
Book Value / Share Growth (5Y)17.52%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.35x
Pretax Margin (Annual)20.59%
Cash / Share (Annual)$4.13
3-Month Return Std Dev26.09%
Gross Margin (5Y Avg)68.12%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)41.01%
EBITDA Interim CAGR (5Y)26.10%
ROE (Last FY)11.76%
Net Interest Coverage (Annual)45.06x
EPS Basic Excl Extra (Annual)$3.92
P/FCF (TTM)22.20x
Receivables Turnover (TTM)4.75x
EV / Free Cash Flow (TTM)21.29x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$3.93
Receivables Turnover (Annual)4.75x
ROI (TTM)12.39%
P/S Ratio (TTM)4.37x
Pretax Margin (5Y Avg)15.70%
Revenue / Share (Annual)$21.44
Tangible BV / Share (Annual)$28.35
Forward P/E21.66x
Free OCF CAGR (5Y)33.79%
Price vs S&P 500 (52W)1.71%
P/E Ratio (TTM)23.90x
EPS Growth TTM (YoY)428.44%
Year-to-Date Return10.89%
5-Day Price Return1.98%
EPS Normalized (Annual)$3.92
ROA (5Y Avg)6.26%
Net Profit Margin (Annual)18.30%
Month-to-Date Return12.37%
Cash Flow / Share (TTM)$2.36
EBITD / Share (Annual)$5.25
EPS Growth (3Y)28.40%
Operating Margin (Annual)20.33%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)17.06x
ROI (5Y Avg)7.13%
P/E Excl Extra (TTM)23.90x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$3.93
P/TBV (Quarterly)3.07x
P/B Ratio (Annual)2.57x
Inventory Turnover (TTM)1.35x
Pretax Margin (TTM)20.59%
Book Value / Share (Annual)$33.86
Price vs S&P 500 (13W)0.74%
Net Margin Growth (5Y)7.13%
Beta1.08x
P/FCF (Annual)22.20x
Revenue / Share (TTM)$21.52
ROE (TTM)12.40%
52-Week Low$51.79
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.86
3.91
3.91
3.91
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
GMEDGLOBUS MEDICAL INC | 4.37x | 30.08% | 67.41% | 20.33% | $96.82 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Globus Medical Inc develops and manufactures medical devices for surgical procedures, with a primary focus on musculoskeletal solutions for spinal and orthopedic surgery. The company serves hospitals, physicians, and surgical centers through two business segments: musculoskeletal surgical devices and enabling surgical technologies. The majority of revenue comes from musculoskeletal products, with over half generated in the United States and the remainder from international operations.